BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kiyashchenko LI, Mileykovskiy BY, Lai YY, Siegel JM. Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area. J Neurophysiol 2001;85:2008-16. [PMID: 11353017 DOI: 10.1152/jn.2001.85.5.2008] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Thorpy MJ. Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management. CNS Drugs 2006;20:43-50. [PMID: 16396523 DOI: 10.2165/00023210-200620010-00004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
2 Nixon JP, Kotz CM, Novak CM, Billington CJ, Teske JA. Neuropeptides controlling energy balance: orexins and neuromedins. Handb Exp Pharmacol 2012;:77-109. [PMID: 22249811 DOI: 10.1007/978-3-642-24716-3_4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
3 Kodama T, Usui S, Honda Y, Kimura M. High Fos expression during the active phase in orexin neurons of a diurnal rodent, Tamias sibiricus barberi. Peptides 2005;26:631-8. [DOI: 10.1016/j.peptides.2004.11.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
4 Manger PR. An examination of cetacean brain structure with a novel hypothesis correlating thermogenesis to the evolution of a big brain. Biol Rev 2006;81:293. [DOI: 10.1017/s1464793106007019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 26] [Article Influence: 7.2] [Reference Citation Analysis]
5 Sukhotinsky I, Hopkins DA, Lu J, Saper CB, Devor M. Movement suppression during anesthesia: Neural projections from the mesopontine tegmentum to areas involved in motor control. J Comp Neurol 2005;489:425-48. [DOI: 10.1002/cne.20636] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
6 Nishino S. Narcolepsy. Sleep Medicine Clinics 2006;1:47-61. [DOI: 10.1016/j.jsmc.2005.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Siegel JM. Rapid Eye Movement Sleep. Principles and Practice of Sleep Medicine. Elsevier; 2017. pp. 78-95.e6. [DOI: 10.1016/b978-0-323-24288-2.00008-8] [Cited by in Crossref: 13] [Article Influence: 2.6] [Reference Citation Analysis]
8 Berridge CW, España RA, Vittoz NM. Hypocretin/orexin in arousal and stress. Brain Res 2010;1314:91-102. [PMID: 19748490 DOI: 10.1016/j.brainres.2009.09.019] [Cited by in Crossref: 115] [Cited by in F6Publishing: 115] [Article Influence: 8.8] [Reference Citation Analysis]
9 Zhang J, Sampogna S, Morales FR, Chase MH. Age-related ultrastructural changes in hypocretinergic terminals in the brainstem and spinal cord of cats. Neuroscience Letters 2005;373:171-4. [DOI: 10.1016/j.neulet.2003.08.085] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
10 Brisbare-roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, Mueller C, Nayler O, van Gerven J, de Haas SL, Hess P, Qiu C, Buchmann S, Scherz M, Weller T, Fischli W, Clozel M, Jenck F. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 2007;13:150-5. [DOI: 10.1038/nm1544] [Cited by in Crossref: 396] [Cited by in F6Publishing: 371] [Article Influence: 26.4] [Reference Citation Analysis]
11 Samuels ER, Szabadi E. Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation. Curr Neuropharmacol 2008;6:235-53. [PMID: 19506723 DOI: 10.2174/157015908785777229] [Cited by in Crossref: 389] [Cited by in F6Publishing: 362] [Article Influence: 32.4] [Reference Citation Analysis]
12 John J, Wu MF, Kodama T, Siegel JM. Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats. J Physiol 2003;548:557-62. [PMID: 12626669 DOI: 10.1113/jphysiol.2002.038729] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.5] [Reference Citation Analysis]
13 Xi M, Chase MH. The injection of hypocretin-1 into the nucleus pontis oralis induces either active sleep or wakefulness depending on the behavioral state when it is administered. Sleep 2010;33:1236-43. [PMID: 20857871 DOI: 10.1093/sleep/33.9.1236] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
14 Snow MB, Fraigne JJ, Thibault-Messier G, Chuen VL, Thomasian A, Horner RL, Peever J. GABA Cells in the Central Nucleus of the Amygdala Promote Cataplexy. J Neurosci 2017;37:4007-22. [PMID: 28209737 DOI: 10.1523/JNEUROSCI.4070-15.2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
15 Takakusaki K, Takahashi K, Saitoh K, Harada H, Okumura T, Kayama Y, Koyama Y. Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J Physiol 2005;568:1003-20. [PMID: 16123113 DOI: 10.1113/jphysiol.2005.085829] [Cited by in Crossref: 74] [Cited by in F6Publishing: 80] [Article Influence: 4.4] [Reference Citation Analysis]
16 Shevchuk NA. Possible use of repeated cold stress for reducing fatigue in chronic fatigue syndrome: a hypothesis. Behav Brain Funct 2007;3:55. [PMID: 17958903 DOI: 10.1186/1744-9081-3-55] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
17 Volgin DV, Malinowska M, Kubin L. Dorsomedial pontine neurons with descending projections to the medullary reticular formation express orexin-1 and adrenergic alpha2A receptor mRNA. Neurosci Lett 2009;459:115-8. [PMID: 19427365 DOI: 10.1016/j.neulet.2009.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
18 Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50. [PMID: 24102345 DOI: 10.1111/bph.12415] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
19 Olarte-Sánchez CM, Valencia Torres L, Body S, Cassaday HJ, Bradshaw CM, Szabadi E. Effect of orexin-B-saporin-induced lesions of the lateral hypothalamus on performance on a progressive ratio schedule. J Psychopharmacol 2012;26:871-86. [PMID: 21926428 DOI: 10.1177/0269881111409607] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
20 Schwarz PB, Yee N, Mir S, Peever JH. Noradrenaline triggers muscle tone by amplifying glutamate-driven excitation of somatic motoneurones in anaesthetized rats. J Physiol 2008;586:5787-802. [PMID: 18845613 DOI: 10.1113/jphysiol.2008.159392] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
21 Kiyashchenko LI, Mileykovskiy BY, Maidment N, Lam HA, Wu MF, John J, Peever J, Siegel JM. Release of hypocretin (orexin) during waking and sleep states. J Neurosci 2002;22:5282-6. [PMID: 12097478 DOI: 20026541] [Cited by in Crossref: 224] [Article Influence: 11.2] [Reference Citation Analysis]
22 Peever JH, Lai YY, Siegel JM. Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism. J Neurophysiol 2003;89:2591-600. [PMID: 12611960 DOI: 10.1152/jn.00968.2002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 71] [Article Influence: 3.2] [Reference Citation Analysis]
23 Mahoney CE, Agostinelli LJ, Brooks JN, Lowell BB, Scammell TE. GABAergic Neurons of the Central Amygdala Promote Cataplexy. J Neurosci 2017;37:3995-4006. [PMID: 28235898 DOI: 10.1523/JNEUROSCI.4065-15.2017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
24 Brown RE, Winston S, Basheer R, Thakkar MM, McCarley RW. Electrophysiological characterization of neurons in the dorsolateral pontine rapid-eye-movement sleep induction zone of the rat: Intrinsic membrane properties and responses to carbachol and orexins. Neuroscience 2006;143:739-55. [PMID: 17008019 DOI: 10.1016/j.neuroscience.2006.08.045] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
25 Kornum BR, Faraco J, Mignot E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol 2011;21:897-903. [PMID: 21963829 DOI: 10.1016/j.conb.2011.09.003] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 8.0] [Reference Citation Analysis]
26 Antelmi E, Pizza F, Franceschini C, Ferri R, Plazzi G. REM sleep behavior disorder in narcolepsy: A secondary form or an intrinsic feature? Sleep Med Rev 2020;50:101254. [PMID: 31931470 DOI: 10.1016/j.smrv.2019.101254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
27 Swick TJ. Parkinson's disease and sleep/wake disturbances. Parkinsons Dis 2012;2012:205471. [PMID: 23326757 DOI: 10.1155/2012/205471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
28 De la Herrán-arita AK, Equihua-benítez AC, Drucker-colín R. Treatment of cataplexy. Expert Opinion on Orphan Drugs 2013;1:199-210. [DOI: 10.1517/21678707.2013.765359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Bridoux A, Moutereau S, Covali-Noroc A, Margarit L, Palfi S, Nguyen JP, Lefaucheur JP, Césaro P, d'Ortho MP, Drouot X. Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without atonia in Parkinson's disease. Nat Sci Sleep 2013;5:87-91. [PMID: 23847436 DOI: 10.2147/NSS.S41245] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
30 Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Muscle tone facilitation and inhibition after orexin-a (hypocretin-1) microinjections into the medial medulla. J Neurophysiol 2002;87:2480-9. [PMID: 11976385 DOI: 10.1152/jn.2002.87.5.2480] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 2.6] [Reference Citation Analysis]
31 Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
32 Perez-Leighton C, Little MR, Grace M, Billington C, Kotz CM. Orexin signaling in rostral lateral hypothalamus and nucleus accumbens shell in the control of spontaneous physical activity in high- and low-activity rats. Am J Physiol Regul Integr Comp Physiol 2017;312:R338-46. [PMID: 28039192 DOI: 10.1152/ajpregu.00339.2016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
33 Hashemi E, Sahbaie P, Davies MF, Clark JD, DeLorey TM. Gabrb3 gene deficient mice exhibit increased risk assessment behavior, hypotonia and expansion of the plexus of locus coeruleus dendrites. Brain Res 2007;1129:191-9. [PMID: 17156762 DOI: 10.1016/j.brainres.2006.10.050] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
34 Zhan S, Che P, Zhao XK, Li N, Ding Y, Liu J, Li S, Ding K, Han L, Huang Z, Wu L, Wang Y, Hu M, Han X, Ding Q. Molecular mechanism of tumour necrosis factor alpha regulates hypocretin (orexin) expression, sleep and behaviour. J Cell Mol Med 2019;23:6822-34. [PMID: 31386303 DOI: 10.1111/jcmm.14566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
35 Novak CM, Levine JA. Central Neural and Endocrine Mechanisms of Non-Exercise Activity Thermogenesis and Their Potential Impact on Obesity: Non-exercise activity thermogenesis. Journal of Neuroendocrinology 2007;19:923-40. [DOI: 10.1111/j.1365-2826.2007.01606.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
36 Blumberg MS, Karlsson KA, Seelke AM, Mohns EJ. The ontogeny of mammalian sleep: a response to Frank and Heller (2003). J Sleep Res 2005;14:91-8. [PMID: 15743339 DOI: 10.1111/j.1365-2869.2004.00430_1.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
37 Karlsson K, Kreider J, Blumberg M. Hypothalamic contribution to sleep–wake cycle development. Neuroscience 2004;123:575-82. [DOI: 10.1016/j.neuroscience.2003.09.025] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 2.4] [Reference Citation Analysis]
38 Teske JA, Billington CJ, Kotz CM. Hypocretin/orexin and energy expenditure. Acta Physiol (Oxf) 2010;198:303-12. [PMID: 20070282 DOI: 10.1111/j.1748-1716.2010.02075.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
39 Wu RN, Hung WC, Chen CT, Tsai LP, Lai WS, Min MY, Wong SB. Firing activity of locus coeruleus noradrenergic neurons decreases in necdin-deficient mice, an animal model of Prader-Willi syndrome. J Neurodev Disord 2020;12:21. [PMID: 32727346 DOI: 10.1186/s11689-020-09323-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Guan JL, Uehara K, Lu S, Wang QP, Funahashi H, Sakurai T, Yanagizawa M, Shioda S. Reciprocal synaptic relationships between orexin- and melanin-concentrating hormone-containing neurons in the rat lateral hypothalamus: a novel circuit implicated in feeding regulation. Int J Obes Relat Metab Disord 2002;26:1523-32. [PMID: 12461668 DOI: 10.1038/sj.ijo.0802155] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 4.9] [Reference Citation Analysis]
41 Teske JA, Mavanji V. Energy expenditure: role of orexin. Vitam Horm 2012;89:91-109. [PMID: 22640610 DOI: 10.1016/B978-0-12-394623-2.00006-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
42 Nishino S, Fujiki N. Neuropeptides as possible targets in sleep disorders. Expert Opin Ther Targets 2007;11:37-59. [PMID: 17150033 DOI: 10.1517/14728222.11.1.37] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
43 Bian K, Liu C, Wang Y, Xue Y, Chen L. Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice. Neurosci Lett 2021;765:136291. [PMID: 34666119 DOI: 10.1016/j.neulet.2021.136291] [Reference Citation Analysis]
44 Baumann CR, Bassetti CL. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter. Sleep Medicine Reviews 2005;9:253-68. [DOI: 10.1016/j.smrv.2005.01.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
45 Grella SL, Neil JM, Edison HT, Strong VD, Odintsova IV, Walling SG, Martin GM, Marrone DF, Harley CW. Locus Coeruleus Phasic, But Not Tonic, Activation Initiates Global Remapping in a Familiar Environment. J Neurosci 2019;39:445-55. [PMID: 30478033 DOI: 10.1523/JNEUROSCI.1956-18.2018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
46 Moreno-balandrn E, Garzn M, Bdalo C, Reinoso-surez F, de Andrs I. Sleep-wakefulness effects after microinjections of hypocretin 1 (orexin A) in cholinoceptive areas of the cat oral pontine tegmentum. European Journal of Neuroscience 2008;28:331-41. [DOI: 10.1111/j.1460-9568.2008.06334.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
47 Nepovimova E, Janockova J, Misik J, Kubik S, Stuchlik A, Vales K, Korabecny J, Mezeiova E, Dolezal R, Soukup O, Kobrlova T, Pham NL, Nguyen TD, Konecny J, Kuca K. Orexin supplementation in narcolepsy treatment: A review. Med Res Rev 2019;39:961-75. [PMID: 30426515 DOI: 10.1002/med.21550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
48 Horowitz SS, Blanchard J, Morin LP. Medial vestibular connections with the hypocretin (orexin) system. J Comp Neurol 2005;487:127-46. [DOI: 10.1002/cne.20521] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 2.3] [Reference Citation Analysis]
49 Siegel JM. REM Sleep*. Principles and Practice of Sleep Medicine. Elsevier; 2011. pp. 92-111. [DOI: 10.1016/b978-1-4160-6645-3.00008-6] [Cited by in Crossref: 14] [Article Influence: 1.3] [Reference Citation Analysis]
50 Xi M, Fung SJ, Yamuy J, Morales FR, Chase MH. Induction of Active (REM) Sleep and Motor Inhibition by Hypocretin in the Nucleus Pontis Oralis of the Cat. Journal of Neurophysiology 2002;87:2880-8. [DOI: 10.1152/jn.2002.87.6.2880] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 2.4] [Reference Citation Analysis]
51 Deadwyler SA, Porrino L, Siegel JM, Hampson RE. Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J Neurosci 2007;27:14239-47. [PMID: 18160631 DOI: 10.1523/JNEUROSCI.3878-07.2007] [Cited by in Crossref: 186] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
52 Kodama T, Kimura M. Arousal effects of orexin-A correlate with GLU release from the locus coeruleus in rats. Peptides 2002;23:1673-81. [DOI: 10.1016/s0196-9781(02)00109-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
53 Smart D, Jerman JC. The physiology and pharmacology of the orexins. Pharmacology & Therapeutics 2002;94:51-61. [DOI: 10.1016/s0163-7258(02)00171-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
54 Ghaemi-jandabi M, Azizi H, Ahmadi-soleimani SM, Semnanian S. Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats. Brain Research Bulletin 2017;130:107-11. [DOI: 10.1016/j.brainresbull.2017.01.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
55 Yamuy J, Fung SJ, Xi M, Chase MH. State-dependent control of lumbar motoneurons by the hypocretinergic system. Exp Neurol 2010;221:335-45. [PMID: 19962375 DOI: 10.1016/j.expneurol.2009.11.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
56 John J, Wu MF, Maidment NT, Lam HA, Boehmer LN, Patton M, Siegel JM. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers. J Physiol 2004;560:587-92. [PMID: 15308685 DOI: 10.1113/jphysiol.2004.070573] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
57 Thannickal TC, Siegel JM, Nienhuis R, Moore RY. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol. 2003;13:340-351. [PMID: 12946023 DOI: 10.1111/j.1750-3639.2003.tb00033.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 4.5] [Reference Citation Analysis]
58 Nishino S. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders. Expert Opinion on Investigational Drugs 2007;16:1785-97. [DOI: 10.1517/13543784.16.11.1785] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
59 Wu MF, John J, Maidment N, Lam HA, Siegel JM. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol 2002;283:R1079-86. [PMID: 12376401 DOI: 10.1152/ajpregu.00207.2002] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 4.4] [Reference Citation Analysis]
60 Wang W, Li Q, Pan Y, Zhu D, Wang L. Influence of hypercapnia on the synthesis of neuropeptides and their receptors in murine brain. Respirology 2013;18:102-7. [PMID: 22882587 DOI: 10.1111/j.1440-1843.2012.02245.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
61 Walling SG, Nutt DJ, Lalies MD, Harley CW. Orexin-A infusion in the locus ceruleus triggers norepinephrine (NE) release and NE-induced long-term potentiation in the dentate gyrus. J Neurosci 2004;24:7421-6. [PMID: 15329388 DOI: 10.1523/JNEUROSCI.1587-04.2004] [Cited by in Crossref: 74] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
62 Hunsley MS, Curtis WR, Palmiter RD. Behavioral and sleep/wake characteristics of mice lacking norepinephrine and hypocretin. Genes Brain Behav 2006;5:451-7. [DOI: 10.1111/j.1601-183x.2005.00179.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]